Albumin Nanoparticles Augment Stem Cell Function
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for augmenting stem cell function in regenerative medicine are slow and ineffective, particularly in treating conditions like burns, where there is a need for quicker and more robust regeneration of tissues, and existing methods struggle to measure the efficacy of stem cell augmentation in solid tissue regeneration.
Innovation Solution
The development of albumin nanoparticles, specifically fibrinogen-coated albumin spheres, which are administered intravenously to enhance stem cell function, stabilize blood vessels, and promote the mobilization of stem cells to damaged areas, thereby improving tissue repair and reducing morbidity and mortality.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If recombinant DNA methods or naturally derived molecules are used to increase stem cell production, then stem cell production increases, but treatment time requires several days to weeks
Solution Approach 1:
The patent changes the molecular structure and properties of the augmenting agents by using albumin-bound forms of cytokines (such as G-CSF, GM-CSF, M-CSF, PEG-GM-CSF, PEG-M-CSF) instead of traditional recombinant DNA products. This parameter change in the chemical structure enables faster onset of action while maintaining stem cell production enhancement, directly resolving the contradiction between productivity improvement and time loss.
2Productivity
If small mimetic molecules are used to stimulate mature blood cell formation, then cell formation is stimulated, but long-term side effects occur such as thrombosis and increased bone marrow reticulin
Solution Approach 1:
The patent creates composite structures by binding cytokines to albumin molecules, forming albumin-cytokine conjugates. This composite material approach allows the therapeutic agent to maintain efficacy in stimulating blood cell formation while the albumin component reduces harmful side effects, thus resolving the contradiction between productivity improvement and harmful factor generation.
Solution Approach 2:
Albumin serves as an intermediary carrier that delivers cytokines to target cells. This intermediary approach allows the cytokines to exert their stimulatory effect on blood cell formation while the albumin structure modulates the interaction to minimize harmful effects like thrombosis and bone marrow reticulin accumulation.
3Ease of operation
If stem cells are mobilized from production site to needed site, then patient benefit increases, but measurement of efficacy becomes difficult in solid tissue regeneration
Solution Approach 1:
The patent establishes feedback mechanisms by using albumin-bound cytokines that can be tracked and measured more easily than traditional stem cell mobilization methods. The albumin-cytokine conjugates provide measurable parameters for assessing stem cell activation and tissue regeneration efficacy, resolving the contradiction between ease of operation and difficulty of detection.
Data Source
AI summary
The present invention relates to a product and method of using albumin nanoparticles for augmenting the function or effectiveness of stem cells or precursor cells in vivo. An albumin nanoparticle suspension containing submicron albumin spheres is prepared, with the albumin spheres being capable of augmenting a function and effectiveness of stem cells or precursor cells in vivo. A predetermined amount of the albumin nanoparticle suspension is administered to a patient before or after an onset of at least one condition. The condition is one that can benefit from a healing effect of the stem cells or precursor cells. A function of the stem cells or precursor cells are augmented or improved by the albumin spheres to repair cellular or tissue damage, resulting in decreasing mortality or morbidity of the patient. The albumin spheres can be bound with fibrinogen molecules in vitro or in vivo.